Filing Details

Accession Number:
0001209191-21-040884
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-06-16 16:04:48
Reporting Period:
2021-06-14
Accepted Time:
2021-06-16 16:04:48
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1358762 Reata Pharmaceuticals Inc RETA Pharmaceutical Preparations (2834) 113651945
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1662392 John Colin Meyer 5320 Legacy Drive
Plano TX 75024
Chief Research Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Class A Common Stock Acquisiton 2021-06-14 5,000 $0.00 77,000 No 4 C Direct
Class A Common Stock Disposition 2021-06-14 12,615 $143.54 64,385 No 4 S Direct
Class A Common Stock Disposition 2021-06-14 4,225 $144.44 60,160 No 4 S Direct
Class A Common Stock Disposition 2021-06-14 2,760 $145.49 57,400 No 4 S Direct
Class A Common Stock Disposition 2021-06-14 400 $146.15 57,000 No 4 S Direct
Class A Common Stock Disposition 2021-06-15 3,814 $139.14 53,186 No 4 S Direct
Class A Common Stock Disposition 2021-06-15 4,107 $139.98 49,079 No 4 S Direct
Class A Common Stock Disposition 2021-06-15 6,494 $141.09 42,585 No 4 S Direct
Class A Common Stock Disposition 2021-06-15 12,518 $142.08 30,067 No 4 S Direct
Class A Common Stock Disposition 2021-06-15 8,867 $142.83 21,200 No 4 S Direct
Class A Common Stock Disposition 2021-06-15 2,483 $143.98 18,717 No 4 S Direct
Class A Common Stock Disposition 2021-06-15 1,217 $145.11 17,500 No 4 S Direct
Class A Common Stock Disposition 2021-06-15 500 $145.92 17,000 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 C Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Class A Common Stock Class B common stock Disposition 2021-06-14 5,000 $0.00 5,000 $0.00
Class B Common Stock Employee Stock Option (right to buy) Disposition 2021-06-16 19,525 $0.00 19,525 $11.62
Class A Common Stock Class B common Stock Acquisiton 2021-06-16 19,525 $11.62 19,525 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
54,779 No 4 C Direct
0 2023-06-15 No 4 M Direct
74,304 No 4 M Direct
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Class B Common Stock Employee Stock Option (right to buy) $11.00 2026-05-25 88,636 88,636 Direct
Class B Common Stock Employee Stock Option (right to buy) $22.57 2026-12-07 90,000 90,000 Direct
Class B Common Stock Employee Stock Option (right to buy) $24.75 2027-12-06 87,700 87,700 Direct
Class B Common Stock Employee Stock Option (right to buy) $55.73 2029-01-02 35,500 35,500 Direct
Class B Common Stock Employee Stock Option (right to buy) $55.73 2029-01-02 17,750 17,750 Direct
Class B Common Stock Employee Stock Option (right to buy) $55.73 2029-01-02 17,750 17,750 Direct
Class B Common Stock Employee Stock Option (right to buy) $207.20 2030-01-02 25,000 25,000 Direct
Class A Common Stock Employee Stock Option (right to buy) $121.29 2031-01-04 24,000 24,000 Direct
Expiration Date Amount Remaning Holdings Nature of Ownership
2026-05-25 88,636 88,636 Direct
2026-12-07 90,000 90,000 Direct
2027-12-06 87,700 87,700 Direct
2029-01-02 35,500 35,500 Direct
2029-01-02 17,750 17,750 Direct
2029-01-02 17,750 17,750 Direct
2030-01-02 25,000 25,000 Direct
2031-01-04 24,000 24,000 Direct
Footnotes
  1. The Class B common stock is convertible into Class A common stock on a one-for-one basis at the holder's election at any time. The conversion right of the Class B common stock has no expiration date.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions on one day at prices ranging from $143.05 to $144.04. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions on one day at prices ranging from $144.07 to $145.05. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions on one day at prices ranging from $145.07 to $145.975. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  5. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions on one day at prices ranging from $146.07 to $146.23. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  6. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions on one day at prices ranging from $138.49 to $139.48. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  7. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions on one day at prices ranging from $139.49 to $140.46. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  8. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions on one day at prices ranging from $140.48 to $141.47. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  9. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions on one day at prices ranging from $141.50 to $142.4925. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  10. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions on one day at prices ranging from $142.50 to $143.42. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  11. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions on one day at prices ranging from $143.51 to $144.46. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  12. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions on one day at prices ranging from $144.62 to $145.45. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  13. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions on one day at prices ranging from $145.64 to $146.31. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  14. The options vested in twenty equal quarterly installments beginning on September 15, 2013.
  15. The options vested in sixteen equal quarterly installments beginning on August 25, 2016.
  16. The options vest in twenty equal quarterly installments beginning on March 7, 2017, subject to continued service through each vesting date.
  17. The options vest in sixteen equal quarterly installments beginning on March 6, 2018, subject to continued service through each vesting date.
  18. The options vest in sixteen equal quarterly installments beginning on April 2, 2019, subject to continued service through each vesting date.
  19. On October 14, 2019, based on the satisfaction of certain performance criteria, the option vested as to 4,437 shares and the option was set to vest as to 13,313 shares in twelve equal quarterly installments beginning on January 14, 2020, subject to continued service through each vesting date.
  20. On November 11, 2019, based on the satisfaction of certain performance criteria, the option vested as to 4,437 shares and the option was set to vest as to 13,313 shares in twelve equal quarterly installments beginning on February 11, 2020, subject to continued service through each vesting date.
  21. The options vest in sixteen equal quarterly installments beginning on April 2, 2020, subject to continued service through each vesting date.
  22. The options vest in sixteen equal quarterly installments beginning on April 4, 2021, subject to continued service through each vesting date.